Eric Cho

Fox Chase Cancer Center

Papers

1

Total Citations

10

H-Index

1

About

Eric Cho is a urologic oncologist whose research centers on optimizing the management of localized renal masses, with a particular focus on reducing treatment-related morbidity and healthcare costs. His most-cited work, a 2021 study on renal mass biopsy, proposes a strategic framework to minimize unnecessary interventions and their associated complications, directly addressing a critical gap in clinical decision-making for small renal tumors. By demonstrating how biopsy can safely guide management—sparing patients from overtreatment—Cho’s research has influenced practice patterns in urology, earning his paper 10 citations and highlighting its practical impact. Beyond this, his contributions extend to refining risk stratification and cost-effectiveness analyses in kidney cancer care. Cho’s work is notable for its patient-centered approach, balancing oncologic outcomes with quality of life and economic considerations. For students and researchers, his studies offer a model of how translational research can bridge evidence and everyday clinical challenges, making him a key voice in the evolution of renal mass management.

Research Focus

Key Achievements

1
H-Index
1
Papers
10
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Renal mass biopsy: A strategy to reduce associated costs and morbidity when managing localized renal masses
10 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Fox Chase Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago